provenge
Showing 1 - 25 of 39
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (Sipuleucel-T Injection)
Not yet recruiting
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Sipuleucel-T Injection
- (no location specified)
Nov 10, 2023
Prostate Cancer, Metastatic Prostate Cancer Trial in Tampa (Abiraterone, Enzalutamide, Apalutamide)
Recruiting
- Prostate Cancer
- Metastatic Prostate Cancer
- Abiraterone
- +3 more
-
Tampa, FloridaMoffitt Cancer Center
Feb 21, 2023
Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- Testosterone Cypionate
- Sipuleucel-T
-
New Haven, ConnecticutYale Cancer Center
Oct 20, 2023
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Oklahoma City (Sipuleucel-T)
Not yet recruiting
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Sipuleucel-T
-
Oklahoma City, OklahomaStephenson's Cancer Center
Mar 28, 2023
Prostate Cancer Trial in Madison (sipuleucel-T, DNA Vaccine)
Completed
- Prostate Cancer
- sipuleucel-T
- DNA Vaccine
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Jun 15, 2021
Metastatic Castrate-resistant Prostate Cancer, mCRPC Trial in Dallas (Sipuleucel-T, Stereotactic Ablative Body Radiation)
Completed
- Metastatic Castrate-resistant Prostate Cancer
- mCRPC
- Sipuleucel-T
- Stereotactic Ablative Body Radiation
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Apr 11, 2022
Metastatic Castrate-Resistant Prostate Cancer Treated With
Completed
- Prostate Cancer
- Enzalutamide
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Dec 22, 2020
Prostate Cancer Trial in San Francisco, Houston (SipT Treatment, Ipilimumab)
Prostate Cancer Trial in United States (Radium-223, Sipuleucel-T)
Metastatic Prostate Cancer Trial in United States (Indoximod, Sipuleucel-T, Placebo)
Completed
- Metastatic Prostate Cancer
- Indoximod
- +2 more
-
Chicago, Illinois
- +3 more
Mar 20, 2020
Adenocarcinoma of the Prostate, Bone Metastases, Hormone-resistant Prostate Cancer Trial in Duarte, Pasadena, Salt Lake City
Completed
- Adenocarcinoma of the Prostate
- +5 more
- sipuleucel-T
- +2 more
-
Duarte, California
- +2 more
Aug 21, 2020
Prostate Cancer Trial in Durham (Sipuleucel-T, Lymph Node Biopsy)
Completed
- Prostate Cancer
- Sipuleucel-T
- Lymph Node Biopsy
-
Durham, North CarolinaDuke University Medical Center
Mar 30, 2020
Prostatic Tumors Trial in Augusta (CT-011 (Anti-PD1 Antibody), Sipuleucel-T (Provenge), Cyclophosphamide)
Terminated
- Prostatic Neoplasms
- CT-011 (Anti-PD1 Antibody)
- +2 more
-
Augusta, GeorgiaGeorgia Regents University
Jun 18, 2019
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in United States
Completed
- Castration Levels of Testosterone
- +3 more
- Glycosylated Recombinant Human Interleukin-7
- Laboratory Biomarker Analysis
-
La Jolla, California
- +15 more
Jun 25, 2019
Enrolling Advanced Prostate Cancer Who Are to Receive
Completed
- Castrate Refractory Metastatic Prostate Cancer (mCRPC)
- Provenge
-
Scottsdale, Arizona21st Century Oncology
Jan 8, 2019
Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Nivolumab)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
-
Salt Lake City, UtahHuntsman Cancer Institute at University of Utah
Apr 21, 2022
Prostate Cancer Metastatic, Hormone Refractory Prostate Cancer, Castration-resistant Prostate Cancer Trial in United States
Completed
- Prostate Cancer Metastatic
- +2 more
- sipuleucel-T
- abiraterone acetate
-
La Jolla, California
- +20 more
Mar 5, 2019
Prostate Cancer Trial in Houston (Docetaxel, Sipuleucel-T)
Withdrawn
- Prostate Cancer
- Docetaxel
- Sipuleucel-T
-
Houston, TexasUTHealth Memorial Hermann Cancer Center
Oct 26, 2017
Prostate Cancer Trial in Houston (Sipuleucel-T, Docetaxel)
Withdrawn
- Prostate Cancer
- Sipuleucel-T
- Docetaxel
-
Houston, TexasUTHealth Memorial Hermann Cancer Center
Oct 26, 2017
Prostate Cancer Trial in United States (Control, Sipuleucel-T)
Completed
- Prostate Cancer
- Control
- Sipuleucel-T
-
Berkeley, California
- +17 more
Jun 29, 2017
Metastatic Prostate Cancer Trial in United States (sipuleucel-T, enzalutamide)
Completed
- Metastatic Prostate Cancer
- sipuleucel-T
- enzalutamide
-
Tucson, Arizona
- +18 more
Sep 25, 2018
CTC Immune Checkpoint
Completed
- Prostate Cancer
- CTC biomarker expression prevalence
-
Durham, North CarolinaDuke University Medical Center
Jul 8, 2019
Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Completed
- Advanced Prostate Cancer
- Prostatic Neoplasms
- sipuleucel-T
-
Bessemer, Alabama
- +332 more
Mar 5, 2019
Prostate Cancer, Castrate Resistant Prostate Cancer Trial in Marina del Rey (sipuleucel-T, ipilimumab)
Completed
- Prostate Cancer
- Castrate Resistant Prostate Cancer
-
Marina del Rey, CaliforniaProstate Oncology Specialists, Inc.
Aug 23, 2017